The International AIDS Vaccine Initiative (IAVI) is a nonprofit scientific research organization based in New York, NY, dedicated to developing vaccines and antibodies for HIV, tuberculosis, and emerging infectious diseases. Their work spans from research and development to global access advocacy, with a mission to translate scientific discoveries into affordable, globally accessible public health solutions.
IAVI's innovative approach includes pioneering new vaccination strategies and the discovery of broadly neutralizing antibodies against HIV. They are actively developing next-generation HIV vaccines, advancing promising TB vaccine candidates, and working on vaccine solutions for diseases like Lassa fever, Marburg virus, and Sudan ebolavirus to address global health challenges.
Generated from the website